Beranda › HIV › Distrik Columbia
Uji klinis HIV di Distrik Columbia
9 studi untuk HIV mencari peserta di lokasi di Distrik Columbia.
Kota di Distrik Columbia
Teks studi resmi (Bahasa Inggris)
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Washington D.C.
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07650916El Camino HIV Prevention and Care Study
- La Clínica del Pueblo, Washington D.C.
Menerima peserta
Usia 18 ke atas · Pria · Diperbarui 22 Sep 2026 · NCT07834853A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Whitman-Walker Institute ( Site 1538), Washington D.C.
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07266831Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
- George Washington University, Washington D.C.
Menerima peserta
Usia 45 hingga 80 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT04949464Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- George Washington University, Washington D.C.
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT05663502The DC Cohort Longitudinal HIV Status Neutral Study
- Kaiser Permanente Mid-Atlantic States, Washington D.C.
- Unity Health Care, Washington D.C.
- Georgetown University, Washington D.C.
- dan 11 lainnya
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 2 Feb 2026 · NCT01206920Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)
- HIPS (Harm reduction drop-in center), Washington D.C.
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 88 · Semua jenis kelamin · Diperbarui 31 Okt 2025 · NCT06501781Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
- GSK Investigational Site, Washington D.C.
Menerima pesertaFase 1/2
Usia 6 hingga 12 · Semua jenis kelamin · Diperbarui 19 Sep 2024 · NCT05674656Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
- Whitman-Walker Health, Washington D.C.
Menerima pesertaSukarelawan sehat diterima
Usia 15 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2022 · NCT04855773Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.